Advertisement

Topics

Oxford Therapeutics Consulting Limited Company Profile

23:36 EDT 21st June 2018 | BioPortfolio

Consulting for the phatmaceutical and drug development.

Location

The Magdalen Centre
Oxford
Oxfordshire
OX4 4GA
United Kingdom

Contact

Phone: +44 1865 784874
Fax: +44 1865 784875
Email: jansteiner@oxrx.xom


News Articles [1301 Associated News Articles listed on BioPortfolio]

Oxford University Press to publish Antibody Therapeutics

(Oxford University Press USA) Oxford University Press and the Chinese Antibody Society are pleased to announce their new partnership to launch the journal Antibody Therapeutics this spring.

Forma Therapeutics, University of Oxford partner to advance DUB inhibitors development

Forma Therapeutics and the University of Oxford have entered into a collaboration and license agreement to identify, validate and develop deubiquitinating enzyme (DUB) inhibitors for the treatment of ...

Oxford Firm Recruits Two Partners to Build Drug Discovery AI

e-Therapeutics has teamed up with AI experts Intellegens and Biorelate to improve its technology for computer-based drug discovery.  Based in Oxford, e-Therapeutics has the mission of reducing the ti...

Therapeutics and collaboration in the spotlight at Technology Showcase

This year’s Technology Showcase, held on 13 June at Oxford’s Saïd Business School, attracted a host of leading academics, clinicians and investors to discuss the most exciting commercial opportu...

Forma Therapeutics, University of Oxford to advance development of DUB inhibitors to treat neurodegenerative diseases

Forma Therapeutics and the University of Oxford have entered into a collaboration and license agreement to identify, validate and develop deubiquitinating enzyme (DUB) inhibitors for the treatment of ...

Forma, U. Oxford collaborate on DUBs for neurodegenerative diseases

Forma Therapeutics Holdings LLC and several units of the University of Oxford are collaborating to identify, validate, and develop deubiquitinating enzyme (DUB) inhibitors for neurodegenerative diseas...

Oxford Centre for Haematology launched

The new Oxford Centre for Haematology has been launched with funding from the NIHR Oxford Biomedical Research Centre (BRC), bringing together University of Oxford researchers and clinicians from Oxfor...

Evox Therapeutics expands into new facilities at Oxford Science Park

The exosome therapeutics company announced the expansion will enhance its research and development capabilities and will facilitate its growth

PubMed Articles [1176 Associated PubMed Articles listed on BioPortfolio]

Trends study of diet consulting for discharged patients with acute myocardial infarction in China from 2001 to 2011.

To describe trends in diet consulting at discharge for patients with acute myocardial infarction (AMI) in China from 2001-2011.A representative sample of patients in China admitted to hospital for AMI...

Low-threshold consulting services for dementia : Quality criteria from a provider's point of view.

Low-threshold consulting services are becoming increasingly more important as an addition to outpatient and inpatient services.

Cost-utility Analysis of Routine Anxiety and Depression Screening in Patients Consulting for Osteoarthritis: results from the POST Trial.

To investigate the cost-effectiveness (cost-utility) of introducing general practitioner screening for anxiety and depression in patients consulting with osteoarthritis (OA).

Consulting on bTB in Northern Ireland.

RNA Therapeutics (Almost) Comes of Age: Targeting, Delivery and Endosomal Escape.

Clinical Trials [279 Associated Clinical Trials listed on BioPortfolio]

Oxford Partial Knee Replacement. A Randomized Clinical Trial of Three Implant Types

The purpose of this scientific study is to clarify whether there is a relationship between the appearance of radiolucent lines in bone-cement interphase of the tibial component of the diff...

Comparison of Oxford UKA and Sigma UKA With RSA.

Comparison of two unicompartmental knee arthroplasties (UKA), to see if Sigma UKA performs equally good as the Oxford UKA. The study focuses on how well the arthroplasty is fixated to the ...

A Clinical Investigation of the Oxford® Meniscal Unicompartmental Knee System

The purpose of this study is to collect information on complications and survivorship of patients implanted with the Oxford™ Meniscal Unicompartmental Knee System at multiple sites in th...

Oxford® Partial Knee Kinematics Gait Analysis Study

The objective of this study is to compare the effect on gait of unicompartmental knee arthroplasty (UKA), using the Oxford® Partial Knee, versus total knee arthroplasty (TKA), using the V...

Outcome Analysis of the Oxford Partial Knee Arthroplasty

Prospectively monitor the patients receiving the Oxford Partial knee arthroplasty

Companies [2465 Associated Companies listed on BioPortfolio]

Immunocore Limited

Immunocore Limited is developing innovative biological therapeutics to treat a range of cancers, chronic viral infections and diabetes. Immunocore is a privately owned biotechnology company located ...

Oxford Therapeutics Consulting Limited

Consulting for the phatmaceutical and drug development.

Oxford Healthcare Technology

Oxford Healthcare Technology is a staffing firm that leverages their recruiting expertise to deliver experienced healthcare professionals and project teams for consulting engageme...

Isis Innovation

Isis Innovation is the technology transfer company of the University of Oxford, commercialising the research generated by University researchers and owned by the University.Isis Innovation Ltd is a wh...

Accelrys, Inc

The software businesses of the Oxford Molecular Group were incorporated into Accelrys Inc. on June 1, 2001.Oxford Molecular was a leading provider of cheminformatics tools. Founded in 1989, Oxford Mol...

More Information about "Oxford Therapeutics Consulting Limited" on BioPortfolio

We have published hundreds of Oxford Therapeutics Consulting Limited news stories on BioPortfolio along with dozens of Oxford Therapeutics Consulting Limited Clinical Trials and PubMed Articles about Oxford Therapeutics Consulting Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Oxford Therapeutics Consulting Limited Companies in our database. You can also find out about relevant Oxford Therapeutics Consulting Limited Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...


Corporate Database Quicklinks



Searches Linking to this Company Record